Literature DB >> 15842548

Laser Doppler imager (LDI) scanner and intradermal injection for in vivo pharmacology in human skin microcirculation: responses to acetylcholine, endothelin-1 and their repeatability.

Anabelle M Opazo Saez1, Frank Mosel, Jens Nürnberger, U Rushentsova, Mario Gössl, Anna Mitchell, Rafael F Schäfers, Thomas Philipp, René R Wenzel.   

Abstract

AIMS: The purpose of this study was to evaluate the repeatability of forearm skin blood flow responses to intradermal injections of acetylcholine (ACh) and endothelin-1 (ET-1) using a double injection technique (DIT) and a laser Doppler imager (LDI) scanner in the human skin microcirculation.
METHODS: We used a laser Doppler imager (Moor LDI V3.01) to continuously monitor the change in skin blood flow during intradermal administration of physiological saline (0.9% NaCl), acetylcholine (ACh 10(-7), 10(-8), 10(-9) M) and endothelin-1 (ET-1 10(-14), 10(-16), 10(-18) M) in 10 healthy male subjects. Subjects were examined on 3 different days for assessment of interday and interobserver repeatability. Injections of either drug were randomly placed on different sites of the forearm. Laser Doppler images were collected before and after injection at 2.5 min intervals for 30 min. Data were analysed after the completion of each experiment using Moor Software V.3.01. Results are expressed as changes from baseline in arbitrary perfusion units (PU).
RESULTS: ACh caused a significant vasodilation (P < 0.0001 anova, mean +/- SE: 766 +/- 152 PU, ACh 10(-9) M; 1868 +/- 360 PU, ACh 10(-8) M; 4188 +/- 848 PU, ACh 10(-7) M; mean of days 1 and 2, n = 10), and ET-1 induced a significant vasoconstrictive response (P < 0.0001 anova, -421 +/- 83 PU, ET-1 10(-18) M; -553 +/- 66 PU, ET-1 10(-16) M; -936 +/- 90 PU, ET-1 10(-14) M; mean of days 1 and 2, n = 10). There was no difference on the response to either drug on repeated days. Bland-Altman analyses showed a close agreement of responses between days with repeatability coefficients of 1625.4 PU for ACh, and 386.0 PU for ET-1 (95% CI: ACh, -1438 to 1747 PU, ET-1, -399 to 358 PU) and between observers with repeatability coefficients of 1057.2 PU for ACh and 255.8 PU for ET-1 (95% CI: ACh, -1024 to 1048 PU, ET-1, -252 to 249 PU). The variability between these responses was independent of average flux values for both ACh and ET-1. There was a significant correlation between responses measured in the same site, in the same individual on two different days by the same observer (ACh, r = 0.94, P < 0.0001; ET-1, r = 0.90, P < 0.0006), and between responses measured by two different observers (ACh, r = 0.94, P < 0.0001; ET-1, r = 0.91, P < 0.0003).
CONCLUSION: We have shown that interday and intraobserver responses to intradermal injections of ET-1 and ACh, assessed using the DIT in combination with an LDI scanner, exhibited good reproducibility and may be a useful tool for studying the skin microcirculation in vivo.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15842548      PMCID: PMC1884840          DOI: 10.1111/j.1365-2125.2004.02344.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  35 in total

1.  An audit of the use of laser Doppler imaging (LDI) in the assessment of burns of intermediate depth.

Authors:  S A Pape; C A Skouras; P O Byrne
Journal:  Burns       Date:  2001-05       Impact factor: 2.744

2.  Nedocromil sodium inhibits histamine-induced itch and flare in human skin.

Authors:  P Ahluwalia; J I McGill; M K Church
Journal:  Br J Pharmacol       Date:  2001-02       Impact factor: 8.739

3.  Assessment of microvascular endothelial function in human skin.

Authors:  D J Newton; F Khan; J J Belch
Journal:  Clin Sci (Lond)       Date:  2001-12       Impact factor: 6.124

4.  Measurement of depth of burns by laser Doppler perfusion imaging.

Authors:  E J Droog; W Steenbergen; F Sjöberg
Journal:  Burns       Date:  2001-09       Impact factor: 2.744

Review 5.  Endothelin in cardiovascular control: the role of endothelin antagonists.

Authors:  R R Wenzel; P Czyborra; T Lüscher; T Philipp
Journal:  Curr Hypertens Rep       Date:  1999 Feb-Mar       Impact factor: 5.369

6.  Endothelin-A receptor antagonist inhibits angiotensin II and noradrenaline in man.

Authors:  R R Wenzel; J Rüthemann; H Bruck; R F Schäfers; M C Michel; T Philipp
Journal:  Br J Clin Pharmacol       Date:  2001-08       Impact factor: 4.335

7.  The neurogenic vasodilator response to endothelin-1: a study in human skin in vivo.

Authors:  R Katugampola; M K Church; G F Clough
Journal:  Exp Physiol       Date:  2000-11       Impact factor: 2.969

8.  Capsaicin treatment induces histamine release and perfusion changes in psoriatic skin.

Authors:  A L Krogstad; P Lönnroth; G Larson; B G Wallin
Journal:  Br J Dermatol       Date:  1999-07       Impact factor: 9.302

Review 9.  Skin microcirculation in healthy subjects and patients with arteriosclerosis.

Authors:  R R Wenzel; H Bruck; D Baumgart; O Oldenburg; R Erbel; T Philipp
Journal:  Herz       Date:  1999-11       Impact factor: 1.443

10.  Enhanced vasoconstriction to endothelin-1, angiotensin II and noradrenaline in carriers of the GNB3 825T allele in the skin microcirculation.

Authors:  René R Wenzel; Winfried Siffert; H Bruck; Thomas Philipp; Rafael F Schäfers
Journal:  Pharmacogenetics       Date:  2002-08
View more
  9 in total

1.  Direct comparison of laser Doppler flowmetry and laser Doppler imaging for assessment of experimentally-induced inflammation in human skin.

Authors:  Lars J Petersen
Journal:  Inflamm Res       Date:  2013-10-10       Impact factor: 4.575

2.  Low local blood perfusion, high white blood cell and high platelet count are associated with primary tumor growth and lung metastasis in a 4T1 mouse breast cancer metastasis model.

Authors:  Chuan Wang; Ying-Ge Chen; Jian-Li Gao; Gui-Yuan Lyu; Jie Su; Q I Zhang; Xin Ji; Ji-Zhong Yan; Qiao-Li Qiu; Yue-Li Zhang; Lin-Zi Li; Han-Ting Xu; Su-Hong Chen
Journal:  Oncol Lett       Date:  2015-06-02       Impact factor: 2.967

3.  Assessing endothelial dysfunction in adolescents and young adults with type 1 diabetes mellitus using a non-invasive heat stimulus.

Authors:  Amy S Shah; Zhiqian Gao; Lawrence M Dolan; Dana Dabelea; Ralph B D'Agostino; Elaine M Urbina
Journal:  Pediatr Diabetes       Date:  2014-08-01       Impact factor: 4.866

4.  Repeatability of the evaluation of systemic microvascular endothelial function using laser doppler perfusion monitoring: clinical and statistical implications.

Authors:  Eduardo Tibiriçá; Alessandra S M Matheus; Bruno Nunes; Sandro Sperandei; Marilia B Gomes
Journal:  Clinics (Sao Paulo)       Date:  2011       Impact factor: 2.365

5.  A Study to Identify the Optimum Forearm Floss Band Intensity in 29 Young Adults Performing Blood Flow Restriction Training.

Authors:  Yongwoo Lee; JaeLim Choi
Journal:  Med Sci Monit       Date:  2022-03-28

6.  Novel translational model of resolving inflammation triggered by UV-killed E. coli.

Authors:  Madhur P Motwani; Julia D Flint; Roel Ph De Maeyer; James N Fullerton; Andrew M Smith; Daniel Jb Marks; Derek W Gilroy
Journal:  J Pathol Clin Res       Date:  2016-05-04

7.  Novel capsaicin-induced parameters of microcirculation in migraine patients revealed by imaging photoplethysmography.

Authors:  Alexei A Kamshilin; Maxim A Volynsky; Olga Khayrutdinova; Dilyara Nurkhametova; Laura Babayan; Alexander V Amelin; Oleg V Mamontov; Rashid Giniatullin
Journal:  J Headache Pain       Date:  2018-06-18       Impact factor: 7.277

8.  Alteration of skin perfusion in mottling area during septic shock.

Authors:  Hafid Ait-Oufella; Simon Bourcier; Mikael Alves; Arnaud Galbois; Jean-Luc Baudel; Dimitri Margetis; Naike Bige; Georges Offenstadt; Eric Maury; Bertrand Guidet
Journal:  Ann Intensive Care       Date:  2013-09-16       Impact factor: 6.925

9.  The immediate effects of kinesiology taping on cutaneous blood flow in healthy humans under resting conditions: A randomised controlled repeated-measures laboratory study.

Authors:  Gourav Banerjee; Michelle Briggs; Mark I Johnson
Journal:  PLoS One       Date:  2020-02-21       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.